Posted on 12/3/20
Pfizer and BioNTech's Coronavirus Vaccine Approved for Use in the U.K.
It's a milestone development in the global fight against COVID-19. Early on Wednesday, the U.K. became the first Western country to approve a vaccine for use . . .
Posted on 12/2/20
NanoVibronix Announces $6M Private Placement
ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today . . .
Posted on 12/2/20
Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions
Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced the acquisition of rights to Hemera Biosciences, LLC's investigational gene therapy . . .
Posted on 12/2/20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company focused on innovative therapeutics for men's health conditions, today announced the completion of . . .
Posted on 12/2/20
Buffett Buys Pharma: Two Out Of Four Seem Compelling
SummaryBerkshire's latest filing revealed the Oracle of Omaha and his team opening new positions in four pharma giants as of late.From a quality standpoint, all companies . . .
Posted on 12/1/20
Trinity Rehab in Paramus to Host Open House and Ribbon Cutting on Wednesday December 9th
Trinity Rehab, an all-inclusive physical therapy and rehabilitation center providing comprehensive treatment for patients of all ages, walks of life and fitness levels, joins New Jersey . . .
Posted on 12/1/20
Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna
Some Americans could receive COVID-19 vaccinations before the end of 2020. Two coronavirus vaccines are in a prime position to win U.S. emergency use authorization (EUA) . . .
Posted on 12/1/20
Pfizer: A 'New' Growth Foundation In Genomic Medicine
SummaryPfizer has been working on New Pfizer for almost a decade. The spin offs of Consumer Health and Upjohn appear to be the last steps.Continuation of . . .
Posted on 12/1/20
Should You Sell Teladoc Health Stock As Coronavirus Vaccines Succeed?
As the world stands on the verge of getting vaccines for COVID-19, investors interested in the pandemic theme are faced with a dilemma. Do they sell . . .
Posted on 11/30/20
Charlesbank Forms Bridges Consumer Healthcare,Acquires ThermaCare from GSK Consumer Healthcare
Funds affiliated with Charlesbank Capital Partners have announced the formation of Bridges Consumer Healthcare in partnership with industry executives Robert Long and Blair Ramey.
Posted on 11/30/20
Castle Harlan Secures $295 Million Refinancing For Its Portfolio Company, Tensar Corp.
Castle Harlan, a New York private equity firm, today announced that it has secured a $295 million refinancing for its portfolio company, Tensar Corp., headquartered in . . .
Posted on 11/30/20
Where Will Pfizer Be in 5 Years?
Most investors who have been following Pfizer (NYSE:PFE) for awhile can't be overly pleased with how it has fared over the last five years. The big . . .
Posted on 11/30/20
Pfizer's Vaccine Candidate Is Effective -- But It Has Issues
As the excitement over Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) vaccine announcement ebbs, some harsh realities have started to set in. The vaccine candidate -- while a . . .
Posted on 11/30/20
3 Key Advantages Moderna Holds Over Pfizer and AstraZeneca
Pfizer (NYSE:PFE) appears to be likely to be the first drugmaker, along with its partner BioNTech (NASDAQ:BNTX), to win U.S. emergency use authorization (EUA) for a . . .
Posted on 11/30/20
Why Procter & Gamble Is a Retiree's Dream Stock
No single stock is perfect in every possible way. Dividend payments made to shareholders could be instead be invested in growth. Companies that do exceedingly well . . .
Posted on 11/29/20
Advaxis Closes $9.2M Public Offering
PRINCETON, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 11/25/20
MindMed Announces $25 Million Bought Deal Public Offering
Mind Medicine Inc. (NEO: MMED) (OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, is pleased to announce that it has entered into an agreement . . .
Posted on 11/25/20
Should Pfizer Shareholders Sell Their Viatris Stock?
Pfizer's (NYSE:PFE) long-awaited deal is finally done. Last week, the big drugmaker completed its merger of Upjohn with Mylan. The transaction created a new entity, Viatris . . .
Posted on 11/24/20
Quest Diagnostics Earns Gold Status in American Heart Association's 2020 Workplace Health Achievement Index
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2020 . . .
Posted on 11/24/20
Elevian Closes $15 Million Equity Financing
Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential to treat and prevent multiple age-related diseases, today announced the closing . . .
Posted on 11/24/20
Advaxis Prices of $8 Million Public Offering
PRINCETON, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 11/24/20
Better Buy: Gilead Sciences vs. Pfizer
Two healthcare giants have been at the forefront in the fight against COVID-19. Gilead Sciences (NASDAQ:GILD) was among the first companies to win FDA emergency use . . .
Posted on 11/24/20
Advaxis Announces Proposed Public Offering of Common Stock
PRINCETON, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 11/23/20
ATAI Life Sciences Closes $125 Million Series C Financing
ATAI Life Sciences, a global biotech company developing psychedelic and non-psychedelic compounds for various mental health indications, today announced the successful closing of its $125 million . . .
Posted on 11/23/20
BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended September 30, 2020 . . .
New York
